TrialArthritis research & therapy2021

Safety and efficacy of low-dose intravenous arsenic trioxide in systemic lupus erythematosus: an open-label phase IIa trial (Lupsenic).

Mohamed Hamidou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.